| Market Capitalization (Millions $) |
163 |
| Shares
Outstanding (Millions) |
31 |
| Employees |
152 |
| Revenues (TTM) (Millions $) |
21 |
| Net Income (TTM) (Millions $) |
-109 |
| Cash Flow (TTM) (Millions $) |
2 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
The company is a commercial pharmaceutical firm focused on developing and commercializing therapies to improve vision. It developed and launched VIZZ®, the first FDA-approved aceclidine-based eye drop for treating presbyopia, which improves near vision without the need for reading glasses. The company is commercializing VIZZ in the U.S. and establishing international licensing and distribution partnerships for global access.
Company Address: 201 Lomas Santa Fe Dr., Suite 300 Solana Beach 92075 CA
Company Phone Number: 925-7000 Stock Exchange / Ticker: NASDAQ LENZ
|
0.16% 
100 %